Federal Supply Schedule 36F79725D0148

Award Date 6/1/25
Last Date to Order 5/31/30
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This is a Federal Supply Schedule contract awarded by the Veterans Integrated Service Network 12 (VISN 12) to Ajanta Pharma USA Inc. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance from December 2, 2024 to May 31, 2025. As a Federal Supply Schedule contract, this vehicle allows VISN 12, which is a civilian federal agency, to procure pharmaceutical and...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government, to Aurobindo Pharma USA Inc., a foreign-owned for-profit organization. The contract was awarded on March 15, 2020, with a ceiling value of $700,000.00 and a period of performance ending on March 14, 2026. The contract scope covers the procurement of drugs, pharmaceuticals, and hematology-related products under the General Services...
The Federal Supply Schedule (FSS) contract award with ID 36F79723D0101 was issued by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract has a maximum value of $500,000.00 and a period of performance from April 1, 2023 to March 31, 2028. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the FSS contract category 65 I B. The prime contractor awarded this multiple-award contract is...
The Federal Supply Schedule contract award 36F79719D0259 was issued by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to the prime contractor Antares Pharma Inc. The contract, categorized under FSS-61-IB for Pharmaceuticals and Drugs, has a ceiling value of $8,334,100.00 and a period of performance through September 14, 2025. The contract aims to procure a range of drugs, pharmaceuticals, and hematology-related products from the manufacturer Antares Pharma...
The Federal Supply Schedule contract 36F79721D0131 was awarded by the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 12 to NS Pharma, Inc., a foreign-owned for-profit manufacturer, on March 15, 2021. The contract is a multiple award under FSS-61-IB, Pharmaceuticals and Drugs, with a ceiling value of $225,000.00 and a period of performance through March 14, 2026. The purpose of this contract is to provide the VA with a range of pharmaceutical and hematology-related...
This is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Apnar Pharma, LP, a minority-owned small disadvantaged business. The contract, with a ceiling value of $2,225,000.00, is for the provision of pharmaceutical and hematology-related products under FSS Schedule 65 IB. The contract has a period of performance from June 15, 2021 to June 14, 2026. As an FSS contract, it allows for the placement of task orders by federal agencies for the...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government, to Pharmaessentia USA Corp, a foreign-owned for-profit organization. The contract is for the provision of Drugs, Pharmaceuticals, & Hematology Related Products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. The contract has a ceiling value of $6,000,000.00 and a period of performance from June 1, 2022 to May 31,...
This Federal Supply Schedule (FSS) contract award with ID 36F79720D0103 was issued by the Veterans Integrated Service Network 12 (VISN 12), a division of the U.S. Department of Veterans Affairs, a civilian federal agency. The contract has a not-to-exceed ceiling value of $389,440.00 and a period of performance through January 31, 2026. The contract was awarded to Analog Pharma, Inc., a for-profit organization, to provide drugs, pharmaceuticals, and hematology-related products under the FSS-61-IB...
The Federal Supply Schedule contract 36F79721D0183 was awarded by the Veterans Integrated Service Network 12 (VISN 12) to Akebia Therapeutics, Inc., a for-profit manufacturer, to provide pharmaceuticals and drugs under the FSS-61-IB Pharmaceuticals and Drugs Master Schedule. This multiple-award contract has a total ceiling value of $40,190,500.00 and a period of performance through June 30, 2026. The contract aims to procure a range of pharmaceutical and hematology-related products to support...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Validus Pharmaceuticals, LLC, a for-profit limited liability company that manufactures goods. The contract has a ceiling value of $2,420,310.00 and a period of performance from April 1, 2023 to March 31, 2028. As a Federal Supply Schedule contract, it is a...
  • 36F79725D0148
    Federal Supply Schedule
  • -
    Blanket Purchase Agreements

The Federal Supply Schedule contract #36F79725D0148 was awarded to Ajanta Pharma USA Inc., a foreign-owned for-profit organization, by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency. The contract is for the provision of drugs, pharmaceuticals, and hematology-related products, classified under FSS category 65 I B, with a ceiling value of $604,940.00 and a period of performance from June 1, 2025 to May 31, 2030. As a multiple award Federal Supply Schedule contract, this vehicle allows VISN 12 and other federal agencies to issue task orders for the procured products and services. The contract does not utilize any set-asides and was awarded to the prime contractor, Ajanta Pharma USA Inc., which is registered in the System for Award Management (SAM) with an expiration date of March 10, 2026.

The purpose of this contract is to provide a streamlined procurement mechanism for federal agencies to acquire a variety of pharmaceutical and hematology-related products from the contractor's pre-negotiated pricing and catalog. The scope of the contract encompasses the delivery of these products to various locations as specified in individual task orders, supporting the overall mission and healthcare needs of VISN 12 and potentially other participating federal agencies.

Generated 6/1/25, 3:28 AM